GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY

FDA recall notice · announced January 7, 2015 · One And Zen

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY

Reason for recall

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.

Notes

Distribution: Nationwide
Lot/code information: All lots
Quantity: 38 bottles
Status: Terminated
Products in this recall event:
- GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY (D-0329-2015)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.